UIPATH INC - CLASS A (PATH) 17.74 -0.24 (-1.33%)
17.74 -0.24 (-1.33%)
US90364P1057 - Common Stock - After market: 17.8199 +0.08 (+0.45%)
Buy % Consensus
Analysts have set a mean price target of 37.76. This target is 112.87% above the current price.
PATH was analyzed by 30 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about PATH.
In the previous month the buy percentage consensus was at a similar level.
PATH was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-27 | Cowen & Co. | Maintains | Outperform |
| 2022-05-20 | Barclays | Maintains | Overweight |
| 2022-05-19 | Morgan Stanley | Maintains | Overweight |
| 2022-05-18 | Wells Fargo | Maintains | Overweight |
| 2022-04-25 | Keybanc | Maintains | Overweight |
| 2022-01-26 | Macquarie | Upgrade | Neutral -> Outperform |
| 2022-01-25 | Macquarie | Upgrade | Neutral -> Outperform |
| 2022-01-20 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2022-01-06 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2021-12-09 | Berenberg | Upgrade | Hold -> Buy |
| 2021-12-09 | Keybanc | Maintains | Overweight |
| 2021-12-09 | Barclays | Maintains | Overweight |
| 2021-12-09 | Wells Fargo | Maintains | Equal-Weight |
| 2021-12-03 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2021-11-16 | Credit Suisse | Initiate | Outperform |
| 2021-10-07 | RBC Capital | Maintains | Sector Perform |
| 2021-09-17 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2021-09-08 | BMO Capital | Maintains | Market Perform |
| 2021-09-08 | Barclays | Maintains | Equal-Weight |
| 2021-09-08 | Cowen & Co. | Maintains | Outperform |
| 2021-09-08 | Wells Fargo | Maintains | Equal-Weight |
| 2021-09-08 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-07-12 | Summit Insights Group | Initiate | Sell |
| 2021-06-09 | BMO Capital | Maintains | Market Perform |
| 2021-06-09 | Keybanc | Maintains | Overweight |
| 2021-06-09 | Barclays | Maintains | Equal-Weight |
| 2021-06-09 | Truist Securities | Maintains | Buy |
| 2021-06-09 | Canaccord Genuity | Maintains | Hold |
| 2021-06-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-05-17 | SMBC Nikko | Initiate | Outperform |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA